Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania

A J Breugom; E Bastiaannet; PG Boelens; LH Iversen; A Martling; R Johansson; T Evans; S Lawton; K M O'Brien; E van Eycken; R Janciauskiene; GJ Liefers; A Cervantes; Valery Lemmens; CJH van de Velde

doi:10.1016/j.ejca.2016.04.017

Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania

A J Breugom, E Bastiaannet, PG Boelens, LH Iversen, A Martling, R Johansson, T Evans, S Lawton, K M O'Brien, E van Eycken, R Janciauskiene, GJ Liefers, A Cervantes, Valery Lemmens, CJH van de Velde

Public Health

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	110-117
Number of pages	8
Journal	European Journal of Cancer
Volume	63
DOIs	https://doi.org/10.1016/j.ejca.2016.04.017
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2016.04.017

http://hdl.handle.net/1765/96461

Cite this

Breugom, A. J., Bastiaannet, E., Boelens, PG., Iversen, LH., Martling, A., Johansson, R., Evans, T., Lawton, S., O'Brien, K. M., van Eycken, E., Janciauskiene, R., Liefers, GJ., Cervantes, A., Lemmens, V., & van de Velde, CJH. (2016). Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania. European Journal of Cancer, 63, 110-117. https://doi.org/10.1016/j.ejca.2016.04.017

@article{794af172a5df4f6d909ffc160657591c,

title = "Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania",

author = "Breugom, {A J} and E Bastiaannet and PG Boelens and LH Iversen and A Martling and R Johansson and T Evans and S Lawton and O'Brien, {K M} and {van Eycken}, E and R Janciauskiene and GJ Liefers and A Cervantes and Valery Lemmens and {van de Velde}, CJH",

year = "2016",

doi = "10.1016/j.ejca.2016.04.017",

language = "Undefined/Unknown",

volume = "63",

pages = "110--117",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Breugom, AJ, Bastiaannet, E, Boelens, PG, Iversen, LH, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, KM, van Eycken, E, Janciauskiene, R, Liefers, GJ, Cervantes, A, Lemmens, V & van de Velde, CJH 2016, 'Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania', European Journal of Cancer, vol. 63, pp. 110-117. https://doi.org/10.1016/j.ejca.2016.04.017

Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania. / Breugom, A J; Bastiaannet, E; Boelens, PG et al.

In: European Journal of Cancer, Vol. 63, 2016, p. 110-117.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania

AU - Breugom, A J

AU - Bastiaannet, E

AU - Boelens, PG

AU - Iversen, LH

AU - Martling, A

AU - Johansson, R

AU - Evans, T

AU - Lawton, S

AU - O'Brien, K M

AU - van Eycken, E

AU - Janciauskiene, R

AU - Liefers, GJ

AU - Cervantes, A

AU - Lemmens, Valery

AU - van de Velde, CJH

PY - 2016

Y1 - 2016

U2 - 10.1016/j.ejca.2016.04.017

DO - 10.1016/j.ejca.2016.04.017

M3 - Article

VL - 63

SP - 110

EP - 117

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -